CSIMarket
 
Quest Diagnostics Inc  (NYSE: DGX)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $235.4600 $-0.04 -0.017%
Day's High: $236.24000549316406 Week Perf: -2.22 %
Day's Low: $ 232.47 30 Day Perf: -0.91 %
Volume (M): 782,154 52 Wk High: $ 247.19
Volume (M$): $ 0 52 Wk Avg: $197.91
Open: $233.58 52 Wk Low: $171.18



 Market Capitalization (Millions $) 26,372
 Shares Outstanding (Millions) 112
 Employees 57,000
 Revenues (TTM) (Millions $) 11,560
 Net Income (TTM) (Millions $) 1,113
 Cash Flow (TTM) (Millions $) 74
 Capital Exp. (TTM) (Millions $) 554

Business Description


Quest Diagnostics Inc.: Overview

Company Profile:
Quest Diagnostics Incorporated is the largest provider of diagnostic testing, information, and related services in the United States. Founded in 1967 and headquartered in Secaucus, New Jersey, Quest is dedicated to providing medical insights that enable healthcare professionals—such as physicians, hospitals, and managed care organizations—to enhance patient health decisions.

Services Provided:
Quest Diagnostics offers a wide array of diagnostic laboratory services. The company is recognized for its extensive national network, which includes numerous laboratories and patient service centers (PSCs). Key offerings include:

1. Diagnostic Testing:
- Quest provides comprehensive laboratory testing services including routine tests, esoteric testing, and specialized testing services such as gene-based assays and toxicology testing for drugs of abuse.

2. Anatomic Pathology Services:
- The company is a leading provider of anatomical pathology services, offering diagnostic test services that include histopathology and biopsies.

3. Clinical Trials:
- Quest supports drug development through laboratory tests and information services in clinical trials, leveraging its expertise in lab sciences to promote patient safety and efficacy assessments.

4. Interpretive Consultation:
- Quest offers professional consultation services with a large team of over 300 medical professionals, including board-certified pathologists and Ph.D.s, who provide interpretive guidance on complex test results to healthcare providers.

5. Information Technology Solutions:
- The company provides advanced IT solutions to healthcare organizations, allowing for improved practice management, patient care documentation, and streamlined workflows—all aimed at enhancing the overall efficiency of healthcare delivery.

Operational Footprint:
Quest Diagnostics operates a vast network, which includes over 2,200 patient service centers, more than 50 laboratory locations nationwide, and a workforce comprising tens of thousands of employees. This extensive infrastructure ensures broad access to testing services for both patients and healthcare providers.

Focus Areas:
- Esoteric Testing: Quest has established itself as a leading provider of esoteric tests, which are specialized tests not commonly performed in routine laboratories. These tests often play a crucial role in diagnosing complex conditions and guiding treatment plans.

- Genomic and Genetic Testing: The company is at the forefront of gene-based testing, including genetic screening and genomic profiling, which are instrumental in personalized medicine and targeted therapy.

- Substance Abuse Testing: Quest offers an array of services for testing drugs of abuse, contributing significantly to the monitoring and detection of substance use disorders across various demographics and sectors, including workplace wellness programs.

Partnerships and Affiliations:
Quest Diagnostics collaborates with healthcare providers, pharmaceutical and biotechnology companies, and research institutions to enhance Healthcare outcomes. The company actively engages in partnerships that facilitate clinical trials and new test development, ensuring it remains integral to evolving healthcare trends.

Regulatory Compliance:
As a key player in the healthcare sector, Quest Diagnostics adheres to stringent regulatory standards imposed by agencies such as the Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP). This commitment to compliance and quality assurance underpins its reputation and trust within the medical community.

Recent Developments and Innovations:
- In recent years, Quest has expanded its offerings to include more robust digital health solutions, augmenting traditional laboratory services with telehealth capabilities, patient-facing applications, and enhanced data analytics.

- The company has also emphasized the importance of corporate social responsibility, focusing on community health programs and addressing health disparities within underserved populations.

Through its innovative services and extensive capabilities, Quest Diagnostics continues to lead the diagnostic testing industry, enhancing patient care and supporting healthcare providers in delivering high-quality medical services.


   Company Address: 500 Plaza Drive Secaucus, 7094 NJ
   Company Phone Number: 520-2700   Stock Exchange / Ticker: NYSE DGX


Customers Net Income grew by DGX's Customers Net Profit Margin grew to

74.13 %

15.12 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
GH   -0.99%    
GRAL   -2.9%    
NTRA        2.98% 
RDNT   -6.16%    
VCYT        0.99% 
XGN        2.67% 
• View Complete Report
   



Business Update

Harnessing Health Insight WHOOP and Quest Diagnostics Redefine Personal Wellness Monitoring,

Published Thu, Sep 18 2025 4:10 PM UTC

The Future of Health Monitoring: WHOOP Partners with Quest Diagnostics for Clinical Lab Testing In a rapidly evolving landscape of health and wellness technology, WHOOP has carved out a unique niche by focusing on human performance enhancement through behavioral insights derived from wearable technology. The company has now taken a significant leap forward by integrating cli...

Product Service News

Quest Diagnostics and Ultima Genomics Forge Groundbreaking Partnership to Revolutionize Oncology and Clinical Diagnostics

Published Tue, Jan 9 2024 1:05 PM UTC

Quest Diagnostics and Ultima Collaborate to Revolutionize Oncology and Clinical Diagnostics with Next-Generation Sequencing TechnologyIn a groundbreaking partnership, Quest Diagnostics, the leading provider of diagnostic information services, and Ultima Genomics, the developer of an innovative ultra-high throughput sequencing architecture, have joined forces to accelerate th...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 24.94
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.28
Price to Sales (Expected) -
Price to Book 3.37
PEG (TTM) 1.99

Financial Strength Current
Quick Ratio 0.4
Working Capital Ratio 1.64
Leverage Ratio (MRQ) 1.18
Total Debt to Equity 0.72
Interest Coverage (TTM) 9.04
Debt Coverage (TTM) 0.41

Per Share Current
Earnings (TTM) 9.44 $
Revenues (TTM) 103.21 $
Cash Flow (TTM) 0.66 $
Cash 6.43 $
Book Value 69.81 $
Dividend (TTM) 3.32 $

Efficiency Current
Revenue per Employee (TTM) 202,807
Net Income per Employee (TTM) 19,526
Receivable Turnover Ratio (TTM) 7.56
Inventory Turnover Ratio (TTM) 37.13
Asset Turnover Ratio (TTM) 0.7

Profitability Ratios Current
Gross Margin (MRQ) 33.75 %
Operating Margin (MRQ) 15.08 %
Net Margin (MRQ) 10.98 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 22.79 %

Management Effectiveness Current
Return On Assets (TTM) 6.71 %
Return On Investment (TTM) 8.38 %
Return On Equity (TTM) 14.85 %
Dividend Yield 1.46 %
Pay out Ratio (TTM) 35.17 %



Quest Diagnostics Inc's Segments
Diagnostic Information Services Business    190.93 % of total Revenue
Other Operating    4.21 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.